110 related articles for article (PubMed ID: 28559943)
1. Unusual Contiguous Soft Tissue Spread of Advanced Malignant Mesothelioma Detected by FDG PET/CT.
Zhang Y; Edwards J; Williams H; Hao Z; Khleif S; Pucar D
Nucl Med Mol Imaging; 2017 Jun; 51(2):178-181. PubMed ID: 28559943
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
3. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
Sharif S; Zahid I; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
[TBL] [Abstract][Full Text] [Related]
4. Extensive Skeletal Muscle Metastases in Malignant Pleural Mesothelioma Detected by FDG PET/CT.
Yilmaz M; Kandemir O; Tutar E
World J Nucl Med; 2023 Dec; 22(4):293-296. PubMed ID: 38152103
[TBL] [Abstract][Full Text] [Related]
5. Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.
Schaefer NG; Veit-Haibach P; Soyka JD; Steinert HC; Stahel RA
Eur J Radiol; 2012 Jan; 81(1):e19-25. PubMed ID: 21129871
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT.
Huang YC; Tu DG; Wu JD; Lee MY
Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799
[TBL] [Abstract][Full Text] [Related]
7. Multiple distant metastases in a case of malignant pleural mesothelioma.
Tertemiz KC; Ozgen Alpaydin A; Gurel D; Savas R; Gulcu A; Akkoclu A
Respir Med Case Rep; 2014; 13():16-8. PubMed ID: 26029551
[TBL] [Abstract][Full Text] [Related]
8. Role of 18F-FDG PET for evaluating malignant pleural mesothelioma.
Nanni C; Castellucci P; Farsad M; Pinto C; Moretti A; Pettinato C; Marengo M; Boschi S; Franchi R; Martoni A; Monetti N; Fanti S
Cancer Biother Radiopharm; 2004 Apr; 19(2):149-54. PubMed ID: 15186594
[TBL] [Abstract][Full Text] [Related]
9. Morphologic and functional imaging of malignant pleural mesothelioma.
Yamamuro M; Gerbaudo VH; Gill RR; Jacobson FL; Sugarbaker DJ; Hatabu H
Eur J Radiol; 2007 Dec; 64(3):356-66. PubMed ID: 17954021
[TBL] [Abstract][Full Text] [Related]
10. What is the best way to diagnose and stage malignant pleural mesothelioma?
Zahid I; Sharif S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy.
Genestreti G; Moretti A; Piciucchi S; Giovannini N; Galassi R; Scarpi E; Burgio MA; Amadori D; Sanna S; Poletti V; Matteucci F; Gavelli G
J Cancer; 2012; 3():241-5. PubMed ID: 22670158
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
Genestreti G; Moretti A; Piciucchi S; Tiseo M; Bersanelli M; Scarlattei M; Scarpi E; Dubini A; Matteucci F; Sanna S
Technol Cancer Res Treat; 2012 Apr; 11(2):163-7. PubMed ID: 22335410
[TBL] [Abstract][Full Text] [Related]
14. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
Pilling J; Dartnell JA; Lang-Lazdunski L
Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576
[TBL] [Abstract][Full Text] [Related]
15. Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma.
Abakay A; Komek H; Abakay O; Palanci Y; Ekici F; Tekbas G; Tanrikulu AC
Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1233-41. PubMed ID: 23690193
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of 18-fluorodeoxyglucose positron emission tomography/computed tomography in malignant pleural mesothelioma.
Terada T; Tabata C; Tabata R; Okuwa H; Kanemura S; Shibata E; Nakano T
Exp Ther Med; 2012 Aug; 4(2):197-200. PubMed ID: 23139709
[TBL] [Abstract][Full Text] [Related]
17. Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma.
Ambrosini V; Rubello D; Nanni C; Farsad M; Castellucci P; Franchi R; Fabbri M; Rampin L; Crepaldi G; Al-Nahhas A; Fanti S
Nucl Med Rev Cent East Eur; 2005; 8(2):111-5. PubMed ID: 16437396
[TBL] [Abstract][Full Text] [Related]
18. False-Negative 18F-Fluorodeoxyglucose PET/CT in Malignant Pleural Mesothelioma.
Corbin H; Packer CD
Cureus; 2021 Aug; 13(8):e17263. PubMed ID: 34540486
[TBL] [Abstract][Full Text] [Related]
19. Imaging before and after multimodal treatment for malignant pleural mesothelioma.
Fiore D; Baggio V; Sotti G; Muzzio PC
Radiol Med; 2006 Apr; 111(3):355-64. PubMed ID: 16683083
[TBL] [Abstract][Full Text] [Related]
20. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
Wilcox BE; Subramaniam RM; Peller PJ; Aughenbaugh GL; Nichols Iii FC; Aubry MC; Jett JR
Clin Lung Cancer; 2009 Jul; 10(4):244-8. PubMed ID: 19632941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
